The FDA says ICU Medical has updated its use instructions for certain IV tubing sets after an investigation found that reported black specks and discoloration in drip chambers do not pose a risk to patients.

The affected products are Plum Administration Sets with drip chambers, IV Non-Dedicated Gravity Administration Sets with drip chambers, IV Sets with drip chambers, and Oncology Sets with drip chambers.

In May 2026, ICU Medical received reports of small black specks and discoloration on the inner wall of drip chambers, along with particulate matter inside the drip chambers of certain IV tubing sets. The concern raised questions about whether the findings represented biological contamination or could enter the fluid path and pose a risk to patients.

ICU Medical investigated, evaluating returned samples, laboratory analysis, simulated-use testing and product inventory. It determined the discoloration is intrinsic to the PVC used to manufacture the drip chamber and remains embedded within the chamber wall.

The investigation found the discolorations are not biological contamination and are not foreign material. They do not enter the fluid path, do not dislodge under expected use conditions, and do not affect the structural integrity or performance of the drip chamber.

"Based on this investigation, the observed discoloration is characteristic of the drip chamber material, does not enter the fluid path, and does not affect device safety, performance, or intended use," the FDA said.

ICU Medical no longer recommends the enhanced inspection activities described in prior communications, and products should continue to be used as intended and per facility protocol.

The investigation did not identify direct patient risk. In some circumstances, a healthcare provider who observes discoloration may elect to replace a product before use, which could delay therapy. Such delays could be clinically significant, especially for time-sensitive, life-saving infusions or when a replacement cannot be readily obtained.

As of July 16, ICU Medical has not reported any serious injuries or deaths associated with the issue. Customers in the U.S. can contact ICU Medical at GlobalComplaints@icumed.com or (866) 261-8806 to report adverse events or product complaints, and at customerservice@icumed.com or (800) 258-5361 for information or technical assistance.